Home › Funds › Ilex Capital Partners (UK) LLP › CRL
Ilex Capital Partners (UK) LLP position in CRL
CHARLES RIV LABS INTL INC · Health Care
Ilex Capital Partners (UK) LLP reported holding 81,193 shares of CRL (CHARLES RIV LABS INTL INC) in its Q2 2026 13F filing — a position valued at US$18.4M, representing 0.38% of its reported portfolio and ranking #45 among its reported holdings. Ilex Capital Partners (UK) LLP has disclosed CRL holdings in 3 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Ilex Capital Partners (UK) LLP's CRL position evolved
Ilex Capital Partners (UK) LLP first disclosed a stake in CRL in Q1 2025 at 10,585 shares (US$1.6M). The position peaked in Q1 2026 at 196,480 shares, worth US$33.9M. Across 3 filings, Ilex Capital Partners (UK) LLP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 81,193 shares valued at US$18.4M — a reduction of -115,287 shares quarter over quarter.. Notable position changes include a 59% trim in Q2 2026 (shares rose 30% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 10.59K | $1.59M | New |
| Q1 2026 | 196.48K | $33.89M | New |
| Q2 2026 | 81.19K | $18.41M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CRL and 13F data
CRL (CHARLES RIV LABS INTL INC) is a Health Care company. 30 other funds we track also report a position in CRL — the largest reported positions include Allspring Global Investments Holdings, LLC (US$436.5M), ARIEL INVESTMENTS, LLC (US$341.6M), EARNEST PARTNERS LLC (US$254.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CRL
- Allspring Global Investments Holdings, LLC 1.91M sh · $436.47M · Q2 2026
- ARIEL INVESTMENTS, LLC 1.51M sh · $341.59M · Q2 2026
- EARNEST PARTNERS LLC 1.12M sh · $254.01M · Q2 2026
- COOKE & BIELER LP 755.63K sh · $171.37M · Q2 2026
More on Ilex Capital Partners (UK) LLP
FAQ
How long has Ilex Capital Partners (UK) LLP held CRL?
Ilex Capital Partners (UK) LLP has disclosed CRL holdings in 3 of the last 6 reported quarters, going back to Q1 2025.
What is Ilex Capital Partners (UK) LLP's current position in CRL?
As of Q2 2026, Ilex Capital Partners (UK) LLP holds 81.19K shares of CRL (CHARLES RIV LABS INTL INC), valued at $18.41M, representing 0.38% of its reported portfolio and ranking #45.
Has Ilex Capital Partners (UK) LLP been buying or selling CRL?
In the latest 13F filing (Q2 2026), Ilex Capital Partners (UK) LLP reduced its position in CRL. The position peaked in Q1 2026 at 196.48K shares.
Which other funds hold CRL?
Other major institutional holders of CRL include Allspring Global Investments Holdings, LLC, ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.